Clinical trial
A Phase II Study of Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis
NCT03268603 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- October 10, 2017
- Completion date
- December 31, 2026
- Enrollment
- 75 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.